|
 |
 |
 |
|
Biz Desk
|
VeriChip Partners IDF To Supply VeriMed
VeriChip and Independent Dialysis Foundation (IDF) announced a partnership to provide the VeriMed Patient Identification System, which consists of the 1st and only FDA-cleared, implantable RFID microchip that links to patients’ medical history, to dialysis patients. The purpose of the partnership is to examine the use of the VeriMed implantable microchip in this patient population.
“VeriChip is deeply committed to supporting the dialysis community and helping to drive improved patient care,” stated Scott Silverman, Chairman & CEO, VeriChip. “Through our partnership with IDF, dialysis patients can receive the implantable microchip and the peace of mind that comes with knowing that their medical history will be available in an emergency – regardless of their ability to communicate. We believe patients receiving dialysis, who tend to present with various co-morbidities and medications and are more frequently admitted to emergency departments, are an important audience to benefit from the Patient Identification System.”
“IDF has always embraced the latest technology as a means to provide our patients with the best possible care,” said Dr. John Sadler, CEO & Founder, IDF. “Improving access to dialysis patients’ medical information by healthcare providers at critical times such as in emergency rooms, through devices such as VeriMed, has the potential to make a significant impact.”
The partnership will provide IDF’s 500 patients and their families access to VeriMed. At the end of one year, VeriMed will be assessed by patient acceptance rates, rate of complications, patient interviews and utility of the information accessed at various points of care.
|
Article Comments
|
Composed: 03-Sep-2008 | Modified: 01-Mar-2009
Post Comment |
Printable Version |
Email Friend |
|
Related Articles:
|
|
|
 |
 |
|
|
